182 related articles for article (PubMed ID: 1969247)
41. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
[TBL] [Abstract][Full Text] [Related]
42. [Tiapride in the treatment of irreversible tardive dyskinesia--initial experiences].
Leblhuber F; Reisecker F; Bengesser G
Z Gerontol; 1987; 20(1):49-51. PubMed ID: 2883781
[TBL] [Abstract][Full Text] [Related]
43. Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial.
Caroff SN; Walker P; Campbell C; Lorry A; Petro C; Lynch K; Gallop R
J Clin Psychiatry; 2007 Mar; 68(3):410-5. PubMed ID: 17388711
[TBL] [Abstract][Full Text] [Related]
44. Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study.
Karniol IG; Portela W
Braz J Med Biol Res; 1982 Dec; 15(6):389-94. PubMed ID: 6135468
[TBL] [Abstract][Full Text] [Related]
45. Effects of amantadine on tardive dyskinesia: a randomized, double-blind, placebo-controlled study.
Pappa S; Tsouli S; Apostolou G; Mavreas V; Konitsiotis S
Clin Neuropharmacol; 2010; 33(6):271-5. PubMed ID: 21121175
[TBL] [Abstract][Full Text] [Related]
46. Baclofen in the treatment of tardive dyskinesia.
Nair NP; Yassa R; Ruiz-Navarro J; Schwartz G
Am J Psychiatry; 1978 Dec; 135(12):1562-3. PubMed ID: 31097
[No Abstract] [Full Text] [Related]
47. Changes in tardive dyskinesia symptoms in elderly patients treated with ganglioside GM1 or placebo.
Sommer BR; Cohen BM; Satlin A; Cole JO; Jandorf L; Dorsey F
J Geriatr Psychiatry Neurol; 1994; 7(4):234-7. PubMed ID: 7826493
[TBL] [Abstract][Full Text] [Related]
48. Tardive dyskinesia with quetiapine.
Ghelber D; Belmaker RH
Am J Psychiatry; 1999 May; 156(5):796-7. PubMed ID: 10327920
[No Abstract] [Full Text] [Related]
49. Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone.
Jeste DV; Okamoto A; Napolitano J; Kane JM; Martinez RA
Am J Psychiatry; 2000 Jul; 157(7):1150-5. PubMed ID: 10873925
[TBL] [Abstract][Full Text] [Related]
50. Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E.
Cadet JL; Lohr JB
Ann N Y Acad Sci; 1989; 570():176-85. PubMed ID: 2576510
[No Abstract] [Full Text] [Related]
51. A therapeutic approach to tardive dyskinesia.
Fahn S
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):19-24. PubMed ID: 2858474
[TBL] [Abstract][Full Text] [Related]
52. Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses.
Sajjad SH
Int Clin Psychopharmacol; 1998 Jul; 13(4):147-55. PubMed ID: 9727725
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study.
Libov I; Miodownik C; Bersudsky Y; Dwolatzky T; Lerner V
J Clin Psychiatry; 2007 Jul; 68(7):1031-7. PubMed ID: 17685739
[TBL] [Abstract][Full Text] [Related]
54. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
[TBL] [Abstract][Full Text] [Related]
55. Reserpine and alpha-methyldopa in the treatment of tardive dyskinesia.
Huang CC; Wang RI; Hasegawa A; Alverno L
Psychopharmacology (Berl); 1981; 73(4):359-62. PubMed ID: 6789358
[TBL] [Abstract][Full Text] [Related]
56. The prevalence of tardive dyskinesia.
Kane JM; Woerner M; Lieberman JA; Weinhold P; Florio W; Rubinstein M; Rotrosen J; Kurucz J; Mukherjee S; Bergmann K
Psychopharmacol Bull; 1985; 21(1):136-9. PubMed ID: 2858906
[No Abstract] [Full Text] [Related]
57. Long-term treatment effects of vitamin E for tardive dyskinesia.
Adler LA; Edson R; Lavori P; Peselow E; Duncan E; Rosenthal M; Rotrosen J
Biol Psychiatry; 1998 Jun; 43(12):868-72. PubMed ID: 9627740
[TBL] [Abstract][Full Text] [Related]
58. Carbamazepine in tardive dyskinesia.
Perényi A; Sztaniszláv D
Psychopharmacol Bull; 1985; 21(2):345-6. PubMed ID: 2860696
[No Abstract] [Full Text] [Related]
59. Sulpiride in tardive dyskinesia.
Casey DE; Gerlach J; Simmelsgaard H
Psychopharmacology (Berl); 1979; 66(1):73-7. PubMed ID: 44375
[TBL] [Abstract][Full Text] [Related]
60. Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole.
Grant MJ; Baldessarini RJ
Ann Pharmacother; 2005 Nov; 39(11):1953. PubMed ID: 16219895
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
